Lastest Stories by Jon C. Ogg

Two investing themes have become much more dominant of late. One concerns climate change, and the other has a partial overlap as it covers the theme of environmental, social and governance strategies.
Tuesday's top analyst upgrades, downgrades and initiations included Amazon.com, Apple, Bed Bath & Beyond, BP, GameStop, Meet, PTC, Total, Visa and Wynn Resorts.
While much attention has been given to efforts of moving beyond fossil fuel use in the twenty-first century, many infrastructure entities from utilities to investment companies to government-related...
The Institute of International Finance has issued its latest outlook on debt. 24/7 Wall St. wanted to put some of the overgrowing debt into context in U.S. terms.
Monday's top analyst upgrades, downgrades and initiations included Alexion, American Water Works, Apple, Schwab, Crowdstrike, FedEx, IBM, Microsoft, Nvidia, Ryanair and Tesla.
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
The United States has now gone 10 straight years with consistent and consecutive jobs growth, after an in-line jobs report on Friday.
Friday's top analyst upgrades, downgrades and initiations included Adobe, Alphabet, Amazon.com, Aurora Cannabis, Dropbox, Facebook, Lyft, Microsoft, Shopify, Snap, Tesla and Uber.
While the initial Employment Situation report for December from the Bureau of labor Statistics has still not been released, it may not much matter in the job market whether the year-end unemployment...
Microsoft is one company that could see its stock contribute handily toward the upside in Dow stocks this year. It seems that Wall Street has already started calibrating its 2020 upside expectations...
Thursday's top analyst upgrades, downgrades and initiations included AMD, Amex, Apache, Coca-Cola, Ford, GM, Goldman Sachs, Lyft, Snap, Starbucks and Tesla.
24/7 Wall St. has reviewed the top six Dow components by weighting, as well as some additional components, that could take the index up by 10% to 12%.
24/7 Wall St. wanted to take a look at where interest rates are heading in 2020, which pertains to credit market metrics for consumers and businesses alike.
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
With the government set to remove Fannie Mae and Freddie Mac from conservatorship, Nomura/Instinet is expecting follow-on capital raises in April of 2021.